MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1161/circulationaha.114.012284

Медицинская библиотека · Circulation · 2014

International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction.

Kristensen Søren L, Køber Lars, Jhund Pardeep S, Solomon Scott D, Kjekshus John, McKelvie Robert S, Zile Michael R, Granger Christopher B, Wikstrand John, Komajda Michel, Carson Peter E, Pfeffer Marc A, Swedberg Karl, Wedel Hans, Yusuf Salim, McMurray John J V

СтатьяРандомизированное исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

International geographic differences in outcomes may exist for clinical trials of heart failure and reduced ejection fraction (HF-REF), but there are few data for those with preserved ejection fraction (HF-PEF).

METHODS AND

RESULTS

We analyzed outcomes by international geographic region in the Irbesartan in Heart Failure with Preserved systolic function trial (I-Preserve), the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM)-Preserved trial, the CHARM-Alternative and CHARM-Added HF-REF trials, and the Controlled Rosuvastatin Multinational Trial in HF-REF (CORONA). Crude rates of heart failure hospitalization varied by geographic region, and more so for HF-PEF than for HF-REF. Rates in patients with HF-PEF were highest in the United States/Canada (HF hospitalization rate 7.6 per 100 patient-years in I-Preserve; 8.8 in CHARM-Preserved), intermediate in Western Europe (4.8/100 and 4.7/100), and lowest in Eastern Europe/Russia (3.3/100 and 2.8/100). The difference between the United States/Canada versus Eastern Europe/Russia persisted after adjustment for key prognostic variables: adjusted hazard ratios 1.34 (95% confidence interval, 1.01-1.74; P=0.04) in I-Preserve and 1.85 (95% confidence interval, 1.17-2.91; P=0.01) in CHARM-Preserved. In HF-REF, rates of HF hospitalization were slightly lower in Western Europe compared with other regions. For both HF-REF and HF-PEF, there were few regional differences in rates of all-cause or cardiovascular mortality.

CONCLUSIONS

The differences in event rates observed suggest there is international geographic variation in 1 or more of the definition and diagnosis of HF-PEF, the risk profile of patients enrolled, and the threshold for hospitalization, which has implications for the conduct of future global trials.

Для цитирования: Kristensen Søren L, Køber Lars, Jhund Pardeep S, Solomon Scott D, Kjekshus John, McKelvie Robert S, Zile Michael R, Granger Christopher B, Wikstrand John, Komajda Michel, Carson Peter E, Pfeffer Marc A, Swedberg Karl, Wedel Hans, Yusuf Salim, McMurray John J V. International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction.. Circulation. 2014. DOI: 10.1161/circulationaha.114.012284.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.